1. Home
  2. NUAI vs ANIK Comparison

NUAI vs ANIK Comparison

Compare NUAI & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo New Era Energy & Digital Inc.

NUAI

New Era Energy & Digital Inc.

HOLD

Current Price

$4.14

Market Cap

190.3M

Sector

Energy

ML Signal

HOLD

Logo Anika Therapeutics Inc.

ANIK

Anika Therapeutics Inc.

HOLD

Current Price

$14.28

Market Cap

191.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUAI
ANIK
Founded
N/A
1983
Country
United States
United States
Employees
N/A
235
Industry
Oil & Gas Production
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
190.3M
191.4M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
NUAI
ANIK
Price
$4.14
$14.28
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$17.00
AVG Volume (30 Days)
3.1M
126.9K
Earning Date
03-12-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
80.16
EPS
N/A
N/A
Revenue
N/A
$112,819,000.00
Revenue This Year
N/A
$5.98
Revenue Next Year
N/A
$7.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.32
$7.90
52 Week High
$9.45
$15.45

Technical Indicators

Market Signals
Indicator
NUAI
ANIK
Relative Strength Index (RSI) 39.29 59.87
Support Level $4.10 $13.70
Resistance Level $5.16 $15.01
Average True Range (ATR) 0.51 0.47
MACD -0.09 -0.14
Stochastic Oscillator 6.95 38.06

Price Performance

Historical Comparison
NUAI
ANIK

About NUAI New Era Energy & Digital Inc.

New Era Energy & Digital Inc is engaged into a fully integrated energy supplier delivering next-gen digital infrastructure and power assets. The company provides turnkey solutions to speed up data center deployment and reduce costs. The company focuses on future-proofing infrastructure for hyperscale, enterprise, and edge operators. The company provide integrated energy and digital solutions to support accelerating AI infrastructure deployment and optimize data center investments.

About ANIK Anika Therapeutics Inc.

Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.

Share on Social Networks: